Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
Clinical trial NCT05775406 · COMPLETED
Trial details
- NCT number
- NCT05775406
- Sponsor
- Kymera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-12-18
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.